Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of November 25th – December 1st, 2019.
Without further ado, let’s get started.
Now That the Bottom is Finally In, These Oversold Pot Stocks Could Make Attractive Investments
2019 Was a Transformational Year for the Cannabis Sector and the Days of Easy Capital Are Over
Heading into 2020, the importance of having a strong and proven investor relations firm has never been greater.
Organigram Reported Q4 Revenue Jumped 411% and Positive Adjusted EBITDA For 2019
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced its financial results for the fourth quarter and full-year fiscal 2019.
Hemp Revenues Drive Total Revenues Up 230.9% in Q3, 380.4% Year-To-Date
Cresco is Showing Signs of Profitability and Continued Organic Growth
Cresco Labs (CSE: CL) (OTCQX: CRLBF) put in a favourable quarter, according to Beacon Securities analyst Russell Stanley, who reviewed the company’s third-quarter earnings in an update to clients on Wednesday.
There Are a Few Things That Still Keep Aurora CEO Terry Booth Up at Night
While the stock of Aurora Cannabis (TSX: ACB) (NYSE: ACB) has indeed suffered, trading down 51% over the past year, Terry Booth continues to remain optimistic about the company’s prospects. Booth highlights how the U.S. remains a crucial market for its CBD product ambitions while reiterating a firm focus on governance and managing its finances to retain investor confidence in an industry beset by steep losses.
Canopy Has Now Received All Necessary Cannabis 2.0 Licences For Marijuana Beverages, Vapes and Edibles
Canopy Growth (TSX: WEED) (NYSE: CGC) announced it has received its Health Canada operating and secure storage licences for the company’s 150,000 sq ft cannabis beverage facility in Smiths Falls, Ontario. The newly licensed beverage facility has already begun the production of cannabis-infused drinks.
The FDA Issued 15 New Warning Letters Yesterday to Cannabis Companies They Believe Are Illegally Selling CBD
The U.S. Food and Drug Administration (FDA) is back in the spotlight after the regulatory body issued 15 new warning letters yesterday to cannabis companies. Cannabis stocks with CBD exposure sold-off in response to the FDA’s confusing warning.
Pot Stocks Have Been Pummelled This Year Amid Regulatory Scandals, Retail Shortages and Black Market Competition
While it’s tough for investors to pick winners in this emerging industry, exchange-traded funds (ETFs) can be an easier – albeit still a speculative bet – for a sector rebound.
Canopy Growth Also Announced 5 New Ontario Retail Locations
Canopy Growth (TSX: WEED) (NYSE: CGC) unveiled its new Cannabis 2.0 portfolio of products at a media event in Toronto, Ontario. Canopy’s new line of products includes beverages, vapes and edibles. On a separate and equally important note, Canopy announced five new retail cannabis stores in the province of Ontario.
Images source: Shutterstock
Move Over Curaleaf, There’s a New MSO in Town and it’s Set to Hit The Street Soon
Get the full details here so you don’t miss out on the next potential 10 bagger.